Dabigatran Reduces Major Cardiovascular Complications in Patients With Myocardial Injury After Noncardiac Surgery
March 11, 2018
March 11, 2018
ORLANDO, Florida, March 11 -- The American College of Cardiology issued the following news release:
Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart attack, stroke and other heart or blood-vessel complications among patients who were at elevated risk for these events because of heart damage that occurred after major noncardiac surgery, according to research being presented at the American College of Cardiology's 67th Annual Scientific . . .
Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart attack, stroke and other heart or blood-vessel complications among patients who were at elevated risk for these events because of heart damage that occurred after major noncardiac surgery, according to research being presented at the American College of Cardiology's 67th Annual Scientific . . .